Loading…

Lopinavir ritonavir Reduces Bupropion Plasma Concentrations in Healthy Subjects

Limited data are available about the effect of steady‐state lopinavir and ritonavir (LPV/r) on bupropion pharmacokinetics. As patients may benefit by using these two agents in combination, this study determined the extent and direction of this drug–drug interaction. Twelve healthy volunteers receive...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2007-01, Vol.81 (1), p.69-75
Main Authors: Hogeland, G W, Swindells, S, McNabb, J C, Kashuba, A D M, Yee, G C, Lindley, C M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Limited data are available about the effect of steady‐state lopinavir and ritonavir (LPV/r) on bupropion pharmacokinetics. As patients may benefit by using these two agents in combination, this study determined the extent and direction of this drug–drug interaction. Twelve healthy volunteers received a single 100 mg dose of sustained‐release bupropion before and after 2 weeks of treatment with LPV/r 400 mg/100 mg twice daily. Pharmacokinetics profiles were determined on days 1 and 30 for bupropion and hydroxybupropion and days 29 and 30 for LPV/r. LPV/r administration significantly decreased bupropion maximum plasma concentration (Cmax) by 57% (90% confidence interval (CI), 38–76% P
ISSN:0009-9236
1532-6535
DOI:10.1038/sj.clpt.6100027